BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 32610295)

  • 1. Habenula deep brain stimulation for intractable schizophrenia: a pilot study.
    Wang Y; Zhang C; Zhang Y; Gong H; Li J; Jin H; Li D; Liu D; Sun B
    Neurosurg Focus; 2020 Jul; 49(1):E9. PubMed ID: 32610295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets.
    Aibar-Durán JÁ; Corripio Collado I; Roldán Bejarano A; Sánchez Nevado R; Aracil Bolanos I; García-Cornet J; Alonso-Solís A; Grasa Bello EM; de Quintana Schmidt C; Muñoz Hernández F; Molet Teixidó J; Rodríguez RR
    J Psychiatr Res; 2023 Jul; 163():296-304. PubMed ID: 37245316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating the Habenula-From Rodents to Humans.
    Boulos LJ; Darcq E; Kieffer BL
    Biol Psychiatry; 2017 Feb; 81(4):296-305. PubMed ID: 27527822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation and digital monitoring for patients with treatment-resistant schizophrenia and bipolar disorder: A case series.
    Bioque M; Rumià J; Roldán P; Hidalgo-Mazzei D; Montejo L; Benabarre A; Gil-Badenes J; Tercero J; Parellada E; Vieta E
    Rev Psiquiatr Salud Ment; 2023 Jun; ():. PubMed ID: 37798202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Brain Stimulation of the Habenula: Systematic Review of the Literature and Clinical Trial Registries.
    Germann J; Mameli M; Elias GJB; Loh A; Taha A; Gouveia FV; Boutet A; Lozano AM
    Front Psychiatry; 2021; 12():730931. PubMed ID: 34484011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Brain Stimulation-Induced Transient Effects in the Habenula.
    Zhang C; Lai Y; Zhang Y; Xu X; Sun B; Li D
    Front Psychiatry; 2021; 12():674962. PubMed ID: 34248713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic analysis of the human habenula in schizophrenia.
    Yalcinbas EA; Ajanaku B; Nelson ED; Garcia-Flores R; Montgomery KD; Stolz JM; Wu J; Divecha HR; Chandra A; Bharadwaj RA; Bach S; Rajpurohit A; Tao R; Shin JH; Kleinman JE; Hyde TM; Weinberger DR; Huuki-Myers LA; Collado-Torres L; Maynard KR
    bioRxiv; 2024 Feb; ():. PubMed ID: 38463979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can brain stimulation benefit individuals with schizophrenia?
    Saudi Med J; 2024 Jan; 45(1):105. PubMed ID: 38220232
    [No Abstract]   [Full Text] [Related]  

  • 9. Using Neuroscientific and Clinical Context to Assess and Manage Changes in Core Personal Traits Caused by Deep Brain Stimulation.
    Hoy CW; Little SJ; Chiong W
    AJOB Neurosci; 2023; 14(3):310-312. PubMed ID: 37682669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation telemedicine programming during the COVID-19 pandemic: treatment of patients with psychiatric disorders.
    Lin Z; Zhang C; Zhang Y; Dai L; Voon V; Li D; Sun B
    Neurosurg Focus; 2020 Dec; 49(6):E11. PubMed ID: 33260128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East.
    Zhang C; Ramirez-Zamora A; Meng F; Lin Z; Lai Y; Li D; Chang J; Morishita T; Inoue T; Fujioka S; Oyama G; Coyne T; Voon V; Doshi PK; Wu Y; Liu J; Patel B; Almeida L; Wagle Shukla AA; Hu W; Foote K; Zhang J; Sun B; Okun MS
    Front Hum Neurosci; 2020; 14():162. PubMed ID: 32733215
    [No Abstract]   [Full Text] [Related]  

  • 12. Deep Brain Stimulation of the Substantia Nigra Pars Reticulata for Treatment-Resistant Schizophrenia: A Case Report.
    Cascella N; Butala AA; Mills K; Kim MJ; Salimpour Y; Wojtasievicz T; Hwang B; Cullen B; Figee M; Moran L; Lenz F; Sawa A; Schretlen DJ; Anderson W
    Biol Psychiatry; 2021 Nov; 90(10):e57-e59. PubMed ID: 33906736
    [No Abstract]   [Full Text] [Related]  

  • 13. Deep brain stimulation for psychiatric disorders: role of imaging in identifying/confirming DBS targets, predicting, and optimizing outcome and unravelling mechanisms of action.
    Georgiev D; Akram H; Jahanshahi M
    Psychoradiology; 2021 Sep; 1(3):118-151. PubMed ID: 38665808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative perspectives in limbic surgery using deep brain stimulation.
    Carrillo-Ruiz JD; Carrillo-Márquez JR; Beltrán JQ; Jiménez-Ponce F; García-Muñoz L; Navarro-Olvera JL; Márquez-Franco R; Velasco F
    Front Neurosci; 2023; 17():1167244. PubMed ID: 37274213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder.
    Gault JM; Hosokawa P; Kramer D; Saks ER; Appelbaum PS; Thompson JA; Olincy A; Cascella N; Sawa A; Goodman W; Moukaddam N; Sheth SA; Anderson WS; Davis RA
    Front Surg; 2023; 10():958452. PubMed ID: 37066004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preclinical study of deep brain stimulation in the ventral tegmental area for alleviating positive psychotic-like behaviors in mice.
    Lu C; Feng Y; Li H; Gao Z; Zhu X; Hu J
    Front Hum Neurosci; 2022; 16():945912. PubMed ID: 36034113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Habenula bibliometrics: Thematic development and research fronts of a resurgent field.
    Chen S; Sun X; Zhang Y; Mu Y; Su D
    Front Integr Neurosci; 2022; 16():949162. PubMed ID: 35990593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: The Habenula and Its Role in Neuropsychiatric Symptoms.
    Gouveia FV; Baker PM; Mameli M; Germann J
    Front Behav Neurosci; 2022; 16():929507. PubMed ID: 35685273
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
    Wada M; Noda Y; Iwata Y; Tsugawa S; Yoshida K; Tani H; Hirano Y; Koike S; Sasabayashi D; Katayama H; Plitman E; Ohi K; Ueno F; Caravaggio F; Koizumi T; Gerretsen P; Suzuki T; Uchida H; Müller DJ; Mimura M; Remington G; Grace AA; Graff-Guerrero A; Nakajima S
    Mol Psychiatry; 2022 Jul; 27(7):2950-2967. PubMed ID: 35444257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Habenula as a Neural Substrate for Aggressive Behavior.
    Gouveia FV; Ibrahim GM
    Front Psychiatry; 2022; 13():817302. PubMed ID: 35250669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.